Evaluation of a Probiotic On Anxiety and Stress in Healthy Adults Sensible to Daily Stress (BIOSTRESS)

Lallemand

Status: Completed

Conditions: Anxiety; Stress

Treatments: Dietary Supplement: PROBIOSTICK® during 30 days; Dietary Supplement: Placebo during 30 days

Study type: Interventional

Funder types: Industry

Identifiers

NCT00807157

BIOSTRESS 11008

Details and patient eligibility

About

The purpose of the the study is to determine if PROBIOSTICK® decrease stress and anxiety of people sensible to daily stress.

Enrollment: 66 estimated patients

Sex: All

Ages: 30 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Caucasian healthy men or women
• Age 30-60 years
• Hospital anxiety and depression score equal or below 12 and above 4
• Standard safety biology

Exclusion criteria

• HAD A results above 12 and below 4
• HAD D results above 12
• Neurologic or psychiatric pathology
• Consumption of psychotropic
• High level of caffeine consumption
• Any important chronic pathology
• Drugs wich impairs concentration, anxiety and stress

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

66 participants in 2 patient groups, including a placebo group

2

Placebo Comparator group

Description:

Every morning subjects will consume a stick of placebo during 30 days

Treatment:

Dietary Supplement: Placebo during 30 days

1

Experimental group

Description:

Every morning subjects will consume a stick of PROBIOSTICK® during 30 days

Treatment:

Dietary Supplement: PROBIOSTICK® during 30 days